The meta-analysis revealed that sulfonylurea has a highly successful rate for treatment NDM due to heterozygous mutations of the genes KCNJ11 andABCC8 encoding the two subunits (Kir6.2 and SUR1) of KATP channel. This evidence concerns the gene KCNJ11 and neonatal diabetes mellitus.